Chia Seeds for Soluble Fiber and Blood Sugar

Chia seeds deliver 34 g of dietary fiber per 100 g — one of the highest fiber-per-gram ratios of any whole food — and that fiber is predominantly the viscous, gel-forming mucilage that surrounds each seed. Viscous soluble fiber is the most clinically powerful form of fiber for metabolic outcomes: it slows gastric emptying, blunts postprandial glucose excursion, binds bile acids to lower LDL cholesterol, ferments to short-chain fatty acids that feed colonocytes and modulate appetite hormones, and supports a healthier gut microbiota. The Vuksan group at the University of Toronto and St. Michael's Hospital has run a series of well-designed randomized crossover trials in type 2 diabetes showing chia delivers clinically meaningful glycemic and cardiovascular benefit. This page covers the mucilage mechanism, the trial evidence in type 2 diabetes and metabolic syndrome, the LDL/triglyceride literature, the prebiotic and microbiota story, and practical positioning of chia as a metabolic-syndrome and pre-diabetes intervention.

Table of Contents

1. Fiber 101: Soluble Versus Insoluble, Viscous Versus Non-Viscous
2. The Chia Mucilage Layer (Composition and Hydration)
3. How Viscosity Slows Glucose Absorption
4. Postprandial Glucose Trials (Vuksan Series)
5. Whole Versus Ground Chia: The Ho 2013 Trial
6. Type 2 Diabetes: The 2017 RCT
7. LDL Cholesterol and the Bile-Acid Mechanism
8. Triglyceride Effects
9. SCFA Fermentation and Gut Microbiota
10. Appetite, Satiety, and Weight
11. Chia Versus Psyllium and Oat Beta-Glucan
12. Practical Protocol
13. Cautions
14. Key Research Papers
15. Connections

Fiber 101: Soluble Versus Insoluble, Viscous Versus Non-Viscous

Not all dietary fiber is the same, and the clinical implications vary substantially by physical-chemical properties. The most useful distinctions are:

• Solubility — whether the fiber dissolves in water. Insoluble fiber (cellulose in vegetable stalks, lignin in wood) passes through the gut largely unchanged and primarily affects bowel transit time and stool bulk. Soluble fiber (pectin in apples, beta-glucan in oats, mucilage in chia and psyllium) dissolves into the aqueous gut contents and can be fermented by colonic bacteria.
• Viscosity — whether the soluble fiber forms a thick gel when dissolved. This distinction is more clinically important than solubility per se. Viscous soluble fibers (mucilage, beta-glucan, psyllium, pectin, guar gum) slow gastric emptying, blunt glucose absorption, and bind bile acids. Non-viscous soluble fibers (inulin, fructooligosaccharides, partially-hydrolyzed guar gum, resistant maltodextrin) ferment well but produce less effect on glucose and cholesterol because they don't increase intestinal contents viscosity.
• Fermentability — whether colonic bacteria can metabolize the fiber to short-chain fatty acids (SCFAs: acetate, propionate, butyrate). Most soluble fibers are fermentable to varying degrees; most insoluble fibers are largely non-fermentable.
• Particle binding — capacity to bind bile acids, dietary cholesterol, drug molecules. Viscous gel-forming fibers and certain charged fibers (lignin, some pectins) are most effective.

Chia mucilage is in the most clinically powerful category: viscous soluble fiber that is also moderately fermentable. This combination delivers the gastric-emptying and bile-acid effects of psyllium plus the SCFA production and microbiota effects of more fermentable fibers like inulin. Few foods occupy this combined niche.

Back to Table of Contents

The Chia Mucilage Layer (Composition and Hydration)

The chia seed itself is small (about 1-2 mm long) and oval, with a hard outer testa surrounding the embryo and storage tissue. The mucilage is a polysaccharide layer in the outer pericarp cells that is released when the seed contacts water. Within seconds to minutes, the mucilage swells and forms a clear or whitish gelatinous layer surrounding the seed, ultimately extending 5-10 seed diameters into the surrounding fluid.

Chemical composition of the mucilage, characterized by Capitani, Munoz, and others:

• Predominantly heteropolysaccharide composed of xylose, glucose, and methyl-glucuronic acid in approximately a 2:1:1 ratio
• Linked through alpha-(1,4) and beta-(1,4) glycosidic bonds in a branched structure
• High molecular weight (estimated ~0.8 to 2 million Daltons) which drives the high viscosity in solution
• Acidic, with pKa around 3-4, which contributes to mucoadhesion and resistance to acid hydrolysis
• The mucilage is approximately 6% of the seed's dry weight, contributing roughly half of the seed's total fiber content

Hydration kinetics: chia seeds absorb water rapidly. The Munoz 2012 microstructure study measured the water absorption capacity at approximately 12× the seed's dry weight within 10 minutes, increasing to ~15× at 60 minutes. The viscosity of the resulting gel is comparable to or higher than commercial psyllium husk preparations at equivalent concentrations.

The mucilage is what makes chia "chia pudding" possible. The seeds in a 1:9 chia-to-liquid ratio (about 1 tablespoon chia in 1/2 cup liquid) will set into a tapioca-pudding-like consistency within 20-30 minutes. The set is reversible by adding more liquid and remixing; the gel is heat-stable and can be cooked into hot dishes without losing structure.

Back to Table of Contents

How Viscosity Slows Glucose Absorption

The mechanism by which viscous soluble fiber blunts postprandial glucose has been studied for decades (the foundational Jenkins 1978 BMJ paper is one of the most cited papers in dietetics). Multiple physical processes contribute:

1. Slowed gastric emptying — the increased viscosity of stomach contents triggers reflex slowing of the pyloric pump. Liquid meals high in viscous fiber empty from the stomach 30-60% more slowly than the same meal without fiber. The slowed delivery to the small intestine spreads glucose absorption over a longer time window, reducing the peak.
2. Physical barrier to enzyme-substrate contact — in the small intestine, the gel-like contents impede the diffusion of amylase, glucoamylase, and other digestive enzymes to their carbohydrate substrates. Starch granules and sugars trapped within the gel matrix are hydrolyzed more slowly, releasing glucose more slowly to the brush border.
3. Reduced unstirred layer diffusion — even after glucose is liberated from carbohydrate substrates, the viscous gel slows its diffusion across the unstirred fluid layer immediately adjacent to the enterocyte brush border. Active and passive glucose transport into enterocytes can only happen as fast as glucose can reach the transporter proteins.
4. Distal small-intestinal delivery — viscous fiber tends to carry some carbohydrate past the proximal jejunum, where most glucose absorption occurs, into the distal ileum. Ileal sensors detect this distal nutrient delivery and release peptides (GLP-1, PYY) that further slow gastric emptying and increase insulin sensitivity — the "ileal brake" mechanism.
5. Reduced insulin demand — because glucose appears in plasma more slowly and over a longer window, less first-phase insulin secretion is required. Over time, this reduced beta-cell demand may help preserve insulin secretory function, particularly important in pre-diabetes and early type 2 diabetes.

The clinical signature of these mechanisms acting together is a measurably lower postprandial glucose peak (typically 20-30% reduction) and reduced glucose area under the curve over 2-3 hours after a carbohydrate meal. The effect is dose-dependent and only present when the fiber is consumed with the meal — fiber consumed an hour before a meal has minimal effect on postprandial glucose for that meal.

Back to Table of Contents

Postprandial Glucose Trials (Vuksan Series)

The Vuksan group at the University of Toronto has run the most rigorous human trials of chia for postprandial glucose. Key findings:

Vuksan et al. 2010 (European Journal of Clinical Nutrition) — 11 healthy volunteers tested in a randomized crossover design with 50 g available carbohydrate from white bread, with or without 7, 15, or 24 g of chia (Salba). Results:

• Dose-dependent reduction in postprandial glucose area under the curve, with the highest chia dose producing approximately 30% reduction
• Dose-dependent increase in self-reported satiety
• Effect was robust and statistically significant at all chia doses tested
• No adverse gastrointestinal effects at the doses used

Ho et al. 2013 (European Journal of Clinical Nutrition) — addressed the practical question of whether whole or ground chia is more effective. 13 healthy subjects in randomized crossover received white-bread meals with either 25 g whole chia or 25 g ground chia. Both forms reduced postprandial glucose equivalently, suggesting that the mucilage release is rapid enough that grinding is not required for glycemic effect. This is in contrast to flax, where whole seeds pass largely intact and grinding is essential for nutrient bioavailability.

Vuksan et al. 2017 (Nutrition, Metabolism & Cardiovascular Diseases) — the largest and most rigorous chia trial in type 2 diabetes (detailed in the next section).

The takeaways for clinical practice:

• The glycemic effect is dose-dependent and clinically meaningful starting at approximately 15 g chia (about 1 tablespoon) per meal
• Whole and ground chia work equally well for this endpoint
• Chia must be consumed with the carbohydrate, not separately
• The effect is similar in magnitude to that achievable with prescription acarbose, an alpha-glucosidase inhibitor used in type 2 diabetes

Back to Table of Contents

Whole Versus Ground Chia: The Ho 2013 Trial

A common clinical question is whether chia must be ground (like flax) for nutrient bioavailability. The Ho et al. 2013 study (European Journal of Clinical Nutrition) directly addressed this for the glycemic endpoint, finding equivalent postprandial glucose reduction with whole and ground chia at 25 g doses. For ALA bioavailability, the Ayerza/Coates animal studies suggest a modest (~15-20%) increase with ground chia, but the absolute difference is small enough that whole chia remains practically useful.

Practical implications:

• For glycemic/satiety/satiation effects: whole and ground are equivalent. Whole is more convenient (no grinding required) and has longer shelf life (the antioxidant-rich seed coat protects the oil from oxidation; ground chia begins oxidizing within weeks).
• For maximum ALA absorption: ground chia gives a small advantage, particularly in older adults or those with reduced digestive efficiency. The trade-off is shorter shelf life.
• For chia pudding and gel applications: whole seeds work better, because the texture is more pleasant and the mucilage releases more controllably. Ground chia in liquid produces a thicker, more gluey texture.
• For baking: ground chia works as a partial flour replacement (typically up to 10-15% of total flour) or as an egg substitute (1 tablespoon ground chia + 3 tablespoons water = 1 egg equivalent). Whole chia in baked goods adds texture and a slight crunch.

Most clinicians recommend whole chia as the default form, switching to ground only if maximum ALA absorption is the explicit goal (e.g., a vegan trying to support omega-3 status with chia as the primary source). Whole chia stored properly is essentially shelf-stable for years; ground chia should be refrigerated and used within months.

Back to Table of Contents

Type 2 Diabetes: The 2017 RCT

The Vuksan et al. 2017 trial (Nutrition, Metabolism & Cardiovascular Diseases) is the most rigorous published chia trial in established type 2 diabetes. 77 overweight or obese patients with type 2 diabetes (mean HbA1c ~7.0%) were randomized in a double-blind, parallel design to either:

1. Salba-chia (30 g per 1000 kcal of dietary energy intake) plus a weight-loss diet, for 6 months
2. Oat bran fiber control (matched for fiber content) plus the same weight-loss diet

Both arms received the same calorie-restricted diet. Results at 6 months:

• Greater weight loss in the chia arm: approximately 1.9 kg versus 0.3 kg in oat bran control
• Greater waist circumference reduction in the chia arm
• Larger reduction in HbA1c (the chia arm trended toward greater HbA1c reduction although the difference did not reach statistical significance in this sample size)
• Greater reduction in C-reactive protein (a systemic inflammation marker)
• Greater reduction in adiponectin (an adipocyte hormone whose changes track insulin sensitivity)
• No safety issues, no excess gastrointestinal complaints over the active control

The trial is important for several reasons. First, it used an active fiber control (oat bran) rather than placebo, making the comparison much more conservative than a chia-versus-nothing test would have been. The chia advantage emerged over a clinically realistic dietary intervention against another respected functional fiber. Second, the inflammation marker reductions (CRP and adiponectin) suggest mechanisms beyond simple glycemic blunting. Third, the 6-month duration is meaningful for understanding sustained effects rather than acute postprandial responses.

The clinical inference is that for patients with established type 2 diabetes or pre-diabetes, daily chia at approximately 30 g (one ounce) is a reasonable evidence-based adjunct to standard medical management, contributing modest improvements in weight, glycemic control, and inflammation. It is not a replacement for metformin, GLP-1 agonists, or insulin where indicated, but it is a meaningful contributor to overall metabolic improvement when combined with the broader lifestyle and pharmacologic management plan.

For more on type 2 diabetes management, see our Type 2 Diabetes page.

Back to Table of Contents

LDL Cholesterol and the Bile-Acid Mechanism

Viscous soluble fiber reduces serum LDL cholesterol by 5-15% in well-controlled trials — a modest but meaningful effect, particularly when added to other lifestyle changes. The mechanism is bile-acid sequestration in the gut:

1. Bile acids are synthesized in the liver from cholesterol and secreted into the small intestine via the bile duct to emulsify dietary fat
2. In healthy enterohepatic recycling, approximately 95% of bile acids are actively reabsorbed in the terminal ileum (via the apical sodium-dependent bile acid transporter) and returned to the liver for reuse
3. When viscous soluble fiber binds bile acids in the gel matrix, the bile acids cannot be efficiently reabsorbed and are instead excreted in feces
4. The liver responds by upregulating cholesterol-7-alpha-hydroxylase (the rate-limiting enzyme in bile acid synthesis) to manufacture replacement bile acids
5. The liver also upregulates LDL receptor expression to take up more circulating cholesterol from blood as substrate for bile-acid synthesis
6. Net effect: serum LDL cholesterol falls

This is the same mechanism by which bile-acid-binding-resin drugs (cholestyramine, colesevelam, colestipol) lower LDL cholesterol. Viscous soluble fiber produces a smaller version of the same effect — about a 5-10% LDL reduction versus 15-25% for prescription bile-acid binders. The advantage of fiber is no drug interactions, no constipation, no fat-soluble vitamin malabsorption (the major adverse effects of bile-acid resins).

Chia-specific cholesterol trial data are mixed. Some trials (Nieman 2009) found no LDL change with chia over 12 weeks in overweight adults, possibly because baseline LDL was not particularly elevated. The Vuksan 2007 Salba trial in type 2 diabetes found modest LDL reduction. The Toscano 2015 follow-up in hypertensives found lipid profile improvement only in subjects with elevated baseline values, consistent with the general pattern that viscous fiber benefits are larger in patients with abnormal starting numbers and smaller in already-healthy populations.

Back to Table of Contents

Triglyceride Effects

Chia reduces serum triglycerides modestly in patients with elevated baseline values. The mechanism is partly the ALA omega-3 content (omega-3 fatty acids reduce hepatic VLDL production and accelerate clearance) and partly the soluble fiber effect on postprandial fat absorption. The Vuksan 2007 trial in type 2 diabetes showed approximately 20% triglyceride reduction over 12 weeks with 37 g/day chia, although the small sample size precludes precise effect-size estimation.

For patients with hypertriglyceridemia >500 mg/dL, prescription-strength omega-3 (Vascepa icosapent ethyl or Lovaza) at 4 g/day is the first-line nutritional intervention and is substantially more effective than chia could be at any practical dose. Chia is a reasonable adjunct for borderline hypertriglyceridemia (150-200 mg/dL) where the patient prefers a whole-food approach over pharmaceutical EPA esters.

The combination of ALA from chia, soluble fiber from chia, and weight loss from chia-induced satiety produces a coordinated triglyceride-lowering effect that is the sum of three smaller mechanisms. None of the mechanisms individually is dramatic, but combined they produce a clinically useful effect in motivated patients.

Back to Table of Contents

SCFA Fermentation and Gut Microbiota

The chia mucilage that survives small-intestinal transit (a substantial fraction, given its viscosity and acid stability) reaches the colon and is fermented by resident bacteria. The major end products of fermentation are short-chain fatty acids (SCFAs):

• Acetate (2-carbon) — the most abundant SCFA, partially absorbed and metabolized systemically; contributes to hepatic cholesterol metabolism
• Propionate (3-carbon) — partially absorbed; competes with acetate for hepatic uptake, may inhibit cholesterol synthesis and improve insulin sensitivity
• Butyrate (4-carbon) — primarily metabolized by colonocytes as their preferred energy substrate; supports colonic epithelial integrity, suppresses colonic inflammation, and may reduce colorectal cancer risk

The bacterial taxa that ferment mucilaginous soluble fiber to SCFAs include Bifidobacterium, Bacteroides, Faecalibacterium prausnitzii, and Akkermansia muciniphila. The latter two are of particular interest because they are inversely correlated with metabolic syndrome, type 2 diabetes, and obesity in observational studies, and they appear to be selectively supported by viscous fermentable fibers like chia mucilage.

Chia-specific microbiota studies are still relatively few, but the broader literature on viscous soluble fibers (oat beta-glucan, psyllium, pectin) consistently shows shifts toward higher Bifidobacterium and Faecalibacterium populations and increased fecal butyrate concentrations. These changes are typically apparent within 2-4 weeks of consistent fiber supplementation.

The downstream effects of SCFA production extend beyond the colon. Propionate and butyrate enter portal circulation and signal to G-protein-coupled receptors (GPR41, GPR43, GPR109A) in adipose tissue, liver, and pancreatic beta cells, with effects on insulin sensitivity, GLP-1 secretion, leptin signaling, and hepatic gluconeogenesis. The SCFA pathway is one of the major mechanisms by which gut microbiota composition influences whole-body metabolism, and it is one of the channels through which chia's mucilage exerts its metabolic effects.

For more on gut microbiota, see our Gut Health page.

Back to Table of Contents

Appetite, Satiety, and Weight

Subjective satiety after a chia-containing meal is consistently higher than after the same meal without chia, in trial settings. The mechanisms:

• Gastric distension — the gel-formed chia mucilage occupies stomach volume and triggers stretch-receptor satiety signaling
• Slowed gastric emptying — food remains in the stomach longer, prolonging the satiety signal beyond the immediate post-meal window
• GLP-1 and PYY release from ileal sensors — the distal nutrient delivery from viscous fiber triggers L-cell hormone release that reduces appetite and slows gastric emptying further
• SCFA-mediated leptin signaling — SCFAs increase leptin secretion from adipocytes (modestly) and may improve hypothalamic leptin sensitivity
• Protein content — the 4-5 g of protein per 28 g serving contributes additional satiety on top of the fiber effect

The translation to actual weight loss is more mixed. The Nieman 2009 trial in overweight adults found no weight loss with 50 g/day chia over 12 weeks without dietary calorie restriction. The Vuksan 2017 trial in type 2 diabetes found greater weight loss with chia versus oat bran when both arms followed a calorie-restricted diet. The pattern suggests chia supports adherence to caloric restriction by improving satiety, but does not produce weight loss in the absence of any dietary change.

Practical recommendation: chia at 20-30 g/day pre-meal is a useful adjunct to a deliberate weight-loss diet, helping with satiety and hunger management. Adding chia to an unchanged diet is unlikely to produce meaningful weight loss but may shift food preferences toward higher-protein, higher-fiber meals over time as the satiety effect becomes familiar.

Back to Table of Contents

Chia Versus Psyllium and Oat Beta-Glucan

Three viscous soluble fibers dominate the metabolic-syndrome and cholesterol-lowering literature: psyllium husk, oat beta-glucan, and chia mucilage. A practical comparison:

• Psyllium husk (from Plantago ovata): the most viscous of the three by per-gram measurement. Strongest LDL-lowering evidence (FDA-approved health claim for 7 g/day soluble fiber lowering coronary heart disease risk). Well-studied for constipation (Metamucil is the prototypical formulation). Disadvantages: bland and gritty texture, requires substantial water with each dose to prevent esophageal/gastric impaction (more risk than chia), and provides little additional nutrition beyond fiber.
• Oat beta-glucan (from oats, particularly oat bran): well-studied for LDL reduction (the FDA-approved oat soluble fiber health claim is for 3 g/day beta-glucan). Pleasant culinary integration (oatmeal). Disadvantages: tied to grain-based meals, modest fiber content per gram of oats (need substantial oat intake to deliver therapeutic beta-glucan dose), and oats contain meaningful amounts of starch that may be undesirable for diabetic patients.
• Chia mucilage: less LDL-lowering than psyllium per gram of fiber but adds substantial ALA omega-3, calcium, magnesium, and protein. Better glycemic effect than oat beta-glucan when matched for total fiber dose. More flexible culinary integration (chia pudding, smoothies, baked goods, simply sprinkled on cereal or yogurt) without the gritty texture of psyllium. Longer shelf life than ground flax or oat bran.

For patients whose primary goal is LDL reduction, psyllium husk at 7-10 g/day is the most evidence-based single fiber. For patients with type 2 diabetes or metabolic syndrome where glycemic control is the priority, chia at 25-35 g/day is well supported. For patients without a specific therapeutic target but pursuing general cardiometabolic health, the combination (chia in food, plus a daily psyllium dose for cholesterol if elevated) covers both bases. Many practitioners simply alternate or combine, since these viscous soluble fibers are not interchangeable but complementary in mechanism.

Back to Table of Contents

Practical Protocol

Dose: 20-35 g/day (about 1.5-2.5 tablespoons), divided across 2-3 meals for sustained glycemic effect.

Timing: chia must be consumed with the carbohydrate-containing meal for postprandial glucose effect. Pre-soaked chia gel mixed into the meal works well; sprinkling whole or ground chia on top of the meal also works.

Preparations:

• Chia pudding — 3 tablespoons chia in 1 cup of milk (dairy or plant), set in the refrigerator overnight. Sweeten with stevia, monk fruit, a small amount of maple syrup, or fruit. Excellent breakfast.
• Chia jam — 2 tablespoons chia mixed with 2 cups crushed berries, set 30 minutes. Reduces or eliminates the need for added sugar in jam recipes.
• Smoothie booster — 1-2 tablespoons chia blended into any smoothie thickens it pleasantly and delivers the fiber benefits.
• Egg replacement in baking — 1 tablespoon ground chia + 3 tablespoons water, let set 5 minutes, use in place of 1 egg.
• Iskiate / chia fresca — 1-2 tablespoons chia in 8 oz water with a squeeze of lime and a pinch of salt; let set 5-10 minutes and drink. Traditional Tarahumara hydration beverage; covered in the Hydration and Endurance deep dive.
• Topping — sprinkled directly onto oatmeal, yogurt, salad, or cereal. Easiest entry point for chia-skeptical eaters.

Starting dose: begin with 1 teaspoon daily and titrate up over 2 weeks to the target dose. The fiber load can cause bloating, gas, or constipation if introduced too rapidly, particularly in individuals not accustomed to high-fiber intake.

Water: ensure adequate fluid intake (at least 2 L/day for adults) when consuming chia. The soluble fiber requires water to function properly in the gut.

Back to Table of Contents

Cautions

• Esophageal impaction risk with dry chia — covered in detail in the ALA Omega-3 deep dive. Always pre-soak or mix into food matrix; never swallow a tablespoon of dry chia followed by water.
• Digestive tolerance — rapid introduction of high-fiber chia can cause bloating, gas, or constipation. Titrate slowly over 2-4 weeks.
• Drug absorption interactions — viscous fiber can reduce the absorption of certain medications taken at the same time. Separate chia intake from prescription medications by at least 2 hours, particularly for levothyroxine, statins, oral antibiotics, and oral contraceptives.
• Hypoglycemia in diabetic patients on sulfonylureas, meglitinides, or insulin — the glycemic-blunting effect of chia is additive with these medications and can produce hypoglycemia. Patients starting daily chia at significant doses should monitor blood glucose more closely and may need medication dose adjustment.
• Diverticulitis flare — during an active diverticulitis episode, low-residue diet is standard care and chia should be paused until resolution. Between flares, the older guidance to avoid all seeds has been retracted and chia consumption is fine.
• Inflammatory bowel disease flare — during active flare of Crohn's or ulcerative colitis, high-fiber foods may exacerbate symptoms and should be reduced. Once in remission, viscous soluble fiber including chia can be reintroduced and may help maintain remission.

Back to Table of Contents

Key Research Papers

1. Vuksan V et al. (2010). Reduction in postprandial glucose excursion and prolongation of satiety from whole grain Salba (Salvia hispanica L.). European Journal of Clinical Nutrition. — PubMed (doi:10.1038/ejcn.2009.159)
2. Vuksan V et al. (2017). Salba-chia in the treatment of overweight and obese patients with type 2 diabetes: a double-blind RCT. Nutr Metab Cardiovasc Dis. — PubMed (doi:10.1016/j.numecd.2016.11.124)
3. Ho H et al. (2013). Effect of whole and ground Salba seeds on postprandial glycemia in healthy volunteers. European Journal of Clinical Nutrition. — PubMed (doi:10.1038/ejcn.2013.5)
4. Jenkins DJA et al. (1978). Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. BMJ. — PubMed (doi:10.1136/bmj.1.6124.1392)
5. Vuksan V et al. (2007). Salba (Salvia hispanica L.) improves cardiovascular risk factors in type 2 diabetes. Diabetes Care. — PubMed (doi:10.2337/dc07-1144)
6. Brown L et al. (1999). Cholesterol-lowering effects of dietary fiber: a meta-analysis. American Journal of Clinical Nutrition. — PubMed (doi:10.1093/ajcn/69.1.30)
7. Anderson JW et al. (2009). Health benefits of dietary fiber. Nutrition Reviews. — PubMed (doi:10.1111/j.1753-4887.2009.00189.x)
8. Munoz LA et al. (2012). Chia seeds: microstructure, mucilage extraction and hydration. Journal of Food Engineering. — PubMed (doi:10.1016/j.jfoodeng.2011.10.005)
9. Capitani MI et al. (2012). Physicochemical and functional characterization of by-products from chia seeds. LWT - Food Science and Technology. — PubMed (doi:10.1016/j.lwt.2012.05.029)
10. Toscano LT et al. (2015). Chia induces clinically discrete weight loss and improves lipid profile only in altered previous values. Nutrición Hospitalaria. — PubMed (doi:10.3305/nh.2015.31.3.8242)
11. Nieman DC et al. (2009). Chia seed does not promote weight loss or alter disease risk factors in overweight adults. Nutrition Research. — PubMed (doi:10.1016/j.nutres.2009.04.004)
12. Kulczynski B et al. (2019). The chemical composition and nutritional value of chia seeds. Nutrients. — PubMed (doi:10.3390/nu11061242)

PubMed Topic Searches

• PubMed: Chia and postprandial glucose
• PubMed: Viscous soluble fiber glycemic
• PubMed: Soluble fiber LDL bile acid
• PubMed: SCFA gut microbiota fiber
• PubMed: Chia mucilage viscosity

Back to Table of Contents

Connections

• Chia Seeds Overview
• Chia Seeds Benefits Hub
• Chia for ALA Omega-3
• Chia for Calcium and Bone
• Chia for Hydration and Endurance
• Type 2 Diabetes
• Insulin Resistance
• Metabolic Syndrome
• High Cholesterol
• Flax Seeds
• Oats (Beta-Glucan)
• Gut Health
• Psyllium Husk
• Gastroenterology
• All Food

Back to Table of Contents